MindWalk Holdings (HYFT) Non Operating Investment Income (2023 - 2025)

MindWalk Holdings (HYFT) reported Non Operating Investment Income of -$192308.5 for Q1 2025, down 1137.97% year-over-year from $18527.3 in Q1 2024, and down 1137.97% quarter-over-quarter from -$15534.2 in Q1 2024.

MindWalk Holdings (HYFT) Non Operating Investment Income (2023 - 2025) Analysis & Trends

MindWalk Holdings (HYFT) has 3 years of Non Operating Investment Income data on file, last reported at -$192308.5 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 235,807.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 230,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 MindWalk Holdings 166.20 Mn 156.06 Mn 1.78 -

Historic Data

Download Data
DateValue
Jan 31, 2025 -192,308.53
Jan 31, 2025 -192,308.53
Jan 31, 2024 -15,534.15
Jan 31, 2024 -15,534.15
Jan 31, 2023 -14,086.49
Jan 31, 2023 -14,086.49